 |
blinatumomab |
|---|---|
| Trade Name | Bincyto� |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-06 00:00:00 |
| Sponsor | Amgen Inc.;1 Amgen Center Drive;Thousand Oaks, California, 91320 |
| |
blinatumomab |
|---|---|
| Trade Name | Bincyto� |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-06 00:00:00 |
| Sponsor | Amgen Inc.;1 Amgen Center Drive;Thousand Oaks, California, 91320 |